razoxane has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudíková, A; Dabrowská, L; Geršl, V; Kolář, F; Mandíková, P; Mikšík, I; Mráz, J; Neckář, J; Popelová, O; Stěrba, M | 1 |
| Elami, A; Houminer, E; Korach, A; Ramu, E; Schneider, A; Schwalb, H | 1 |
2 other study(ies) available for razoxane and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Razoxane; Reactive Oxygen Species; Treatment Outcome | 2012 |
Dexrazoxane prevents myocardial ischemia/reperfusion-induced oxidative stress in the rat heart.
Topics: Animals; Cardiotonic Agents; Chelating Agents; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Oxidative Stress; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Razoxane | 2006 |